Mink Brook Asset Management’s Exagen XGN Stock Holding History

Mink Brook Asset Management’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Buy	475,944 +106,917	+29%	+$403K	0.98%	20
2026 Q1	$1.11M	Buy	369,027 +15,300	+4%	+$59.2K	0.62%	31
2025 Q4	$2.15M	Buy	353,727 +313,727	+784%	+$2.86M	1.36%	18
2025 Q3	$440K	Sell	40,000 -90,000	-69%	-$797K	0.3%	35
2025 Q2	$907K	Buy	+130,000	New	+$790K	0.79%	19

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Mink Brook Asset Management's XGN Position: Q2 2026 in Review

Mink Brook Asset Management increased its Exagen (XGN) stake by 29% in Q2 2026, buying an estimated $403K and bringing the position to 475,944 shares worth $2.21M. The position accounts for 0.98% of the portfolio, ranked #20.

Mink Brook Asset Management first reported a position in XGN in Q2 2025 and has held it in 5 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

Mink Brook Asset Management held 475,944 shares of Exagen worth $2.21M as of Q2 2026.
Mink Brook Asset Management bought 106,917 Exagen shares in Q2 2026, an estimated $403K.
Exagen made up 0.98% of Mink Brook Asset Management's portfolio in Q2 2026, its #20 holding.
Mink Brook Asset Management first reported a position in Exagen in Q2 2025 and has held it in 5 quarters since.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Mink Brook Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.